X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC PHARMA with Fulford India - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs FULFORD INDIA - Comparison Results

FULFORD INDIA 
   Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA FULFORD INDIA ALEMBIC PHARMA/
FULFORD INDIA
 
P/E (TTM) x 26.5 398.8 6.7% View Chart
P/BV x 6.1 6.2 97.4% View Chart
Dividend Yield % 0.8 0.1 918.7%  

Financials

 ALEMBIC PHARMA   FULFORD INDIA
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-16
FULFORD INDIA
Mar-14
ALEMBIC PHARMA/
FULFORD INDIA
5-Yr Chart
Click to enlarge
High Rs792942 84.0%   
Low Rs443450 98.4%   
Sales per share (Unadj.) Rs167.0691.4 24.2%  
Earnings per share (Unadj.) Rs38.211.5 333.0%  
Cash flow per share (Unadj.) Rs42.015.4 273.4%  
Dividends per share (Unadj.) Rs4.002.00 200.0%  
Dividend yield (eoy) %0.60.3 225.5%  
Book value per share (Unadj.) Rs84.9380.0 22.3%  
Shares outstanding (eoy) m188.523.90 4,833.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.71.0 367.2%   
Avg P/E ratio x16.260.7 26.6%  
P/CF ratio (eoy) x14.745.3 32.4%  
Price / Book Value ratio x7.31.8 397.0%  
Dividend payout %10.517.4 60.1%   
Avg Mkt Cap Rs m116,3832,714 4,287.6%   
No. of employees `000NA0.4 0.0%   
Total wages/salary Rs m4,214505 834.4%   
Avg. sales/employee Rs ThNM6,073.0-  
Avg. wages/employee Rs ThNM1,137.4-  
Avg. net profit/employee Rs ThNM100.7-  
INCOME DATA
Net Sales Rs m31,4872,696 1,167.7%  
Other income Rs m55125 43.9%   
Total revenues Rs m31,5422,822 1,117.8%   
Gross profit Rs m10,060-46 -21,680.6%  
Depreciation Rs m72215 4,750.7%   
Interest Rs m3710 387.4%   
Profit before tax Rs m9,35654 17,230.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,16010 22,502.1%   
Profit after tax Rs m7,19445 16,094.6%  
Gross profit margin %31.9-1.7 -1,856.6%  
Effective tax rate %23.117.7 130.6%   
Net profit margin %22.81.7 1,378.3%  
BALANCE SHEET DATA
Current assets Rs m15,0661,738 866.7%   
Current liabilities Rs m7,674545 1,408.9%   
Net working cap to sales %23.544.3 53.0%  
Current ratio x2.03.2 61.5%  
Inventory Days Days6748 138.2%  
Debtors Days Days414 943.8%  
Net fixed assets Rs m8,23712 69,222.3%   
Share capital Rs m37739 966.7%   
"Free" reserves Rs m15,4161,443 1,068.4%   
Net worth Rs m16,0051,482 1,080.0%   
Long term debt Rs m00-   
Total assets Rs m24,5942,077 1,184.3%  
Interest coverage x255.26.7 3,800.6%   
Debt to equity ratio x00-  
Sales to assets ratio x1.31.3 98.6%   
Return on assets %29.42.6 1,126.6%  
Return on equity %44.93.0 1,490.3%  
Return on capital %58.74.3 1,363.0%  
Exports to sales %55.70-   
Imports to sales %10.424.5 42.6%   
Exports (fob) Rs m17,551NA-   
Imports (cif) Rs m3,283659 498.0%   
Fx inflow Rs m17,81117 103,549.4%   
Fx outflow Rs m5,318673 790.0%   
Net fx Rs m12,493-656 -1,904.5%   
CASH FLOW
From Operations Rs m9,30490 10,337.7%  
From Investments Rs m-3,105105 -2,968.3%  
From Financial Activity Rs m-1,959-14 13,894.3%  
Net Cashflow Rs m4,240181 2,349.0%  

Share Holding

Indian Promoters % 74.1 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 2.9 3.8 76.3%  
FIIs % 9.1 0.1 9,100.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 21.2 65.6%  
Shareholders   49,328 4,783 1,031.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   STRIDES SHASUN LTD  AJANTA PHARMA  SUVEN LIFE  DR. DATSONS LABS  CADILA HEALTHCARE  

Compare ALEMBIC PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Post Noon Sell-Off; Infosys Falls 5.4%(Closing)

Share markets in India witnessed a sharp fall in the final minutes of trade. At the closing bell, the BSE Sensex closed lower by 266 points. While, the NSE Nifty finished lower by 83 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Aug 21, 2017 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 8-QTR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS